Hong Kong Healthcare Stocks Rise; Topbio, Grand Pharma Gain Nearly 6%

On August 10, 2026, Hong Kong-listed healthcare and biotech stocks showed active trading. As of the trading session that day, Topbio and Grand Pharmaceutical each rose nearly 6%, while Zai Lab and WuXi AppTec climbed over 4%. Ascletis Pharma-B, WuXi Biologics, and WuXi XDC all gained more than 3%.